Clinical Trial Update: Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging [NA]

View source ↗

Summary

Completed clinical trial evaluating the impact of positron emission tomography (PET) imaging on staging for muscle-invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Muscle-invasive Bladder Cancer | NA | Status: COMPLETED